Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $625M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 2,806,980 | $168M | 26.9% | $47.59 | +6.6% | COM | 03753U106 |
| — | CYMABAY THERAPEUTICS INC | 2,673,750 | $63.15M | 10.1% | $7.72 | — | COM | 23257D103 |
| — | VERONA PHARMA PLC | 2,369,000 | $47.1M | 7.5% | $17.59 | — | SPONSORED ADS | 925050106 |
| INSM | INSMED INC | 1,284,000 | $39.79M | 6.4% | $21.76 | +19.2% | COM PAR $.01 | 457669307 |
| RCUS | ARCUS BIOSCIENCES INC | 1,868,000 | $35.68M | 5.7% | $33.27 | -52.0% | COM | 03969F109 |
| BBIO | BRIDGEBIO PHARMA INC | 706,800 | $28.53M | 4.6% | $30.51 | -1.5% | COM | 10806X102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 707,526 | $28.06M | 4.5% | $25.60 | +14.9% | COM NEW | 15117B202 |
| ROIV | ROIVANT SCIENCES LTD | 2,494,000 | $28.01M | 4.5% | $8.56 | +13.9% | SHS | G76279101 |
| — | ALPINE IMMUNE SCIENCES INC | 1,241,300 | $23.66M | 3.8% | $11.89 | — | COM | 02083G100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 414,000 | $16.87M | 2.7% | $40.76 | — | SPONSORED ADS | 86366E106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,060,100 | $16.4M | 2.6% | $7.11 | — | SPONSORED ADS | 152309100 |
| ANTX | AN2 THERAPEUTICS INC | 664,575 | $13.62M | 2.2% | $7.89 | +112.1% | COM | 037326105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 620,000 | $13.5M | 2.2% | $24.88 | -36.6% | COM | 92790C104 |
| IMVT | IMMUNOVANT INC | 273,289 | $11.51M | 1.8% | $36.80 | 0.0% | COM | 45258J102 |
| DYN | DYNE THERAPEUTICS INC | 792,945 | $10.55M | 1.7% | $12.58 | -22.4% | COM | 26818M108 |
| CYTK | CYTOKINETICS INC | 116,000 | $9.685M | 1.5% | $36.21 | 0.0% | COM NEW | 23282W605 |
| ANNX | ANNEXON INC | 2,050,000 | $9.307M | 1.5% | $4.77 | -48.1% | COM | 03589W102 |
| — | AEROVATE THERAPEUTICS INC | 403,685 | $9.135M | 1.5% | $29.30 | — | COM | 008064107 |
| GOSS | GOSSAMER BIO INC | 9,187,883 | $8.384M | 1.3% | $2.93 | -74.8% | COM | 38341P102 |
| — | RAPT THERAPEUTICS INC | 292,000 | $7.256M | 1.2% | $24.85 | — | COM | 75382E109 |
| — | GLYCOMIMETICS INC | 3,000,000 | $7.08M | 1.1% | $1.26 | — | COM | 38000Q102 |
| — | GRACELL BIOTECHNOLOGIES INC | 596,611 | $5.99M | 1.0% | $10.04 | — | SPONSORED ADS | 38406L103 |
| DNTH | DIANTHUS THERAPEUTICS INC | 554,000 | $5.762M | 0.9% | $12.41 | -11.0% | COM | 252828108 |
| — | RENEO PHARMACEUTICALS INC | 2,250,000 | $3.6M | 0.6% | $6.46 | — | COM | 75974E103 |
| — | JASPER THERAPEUTICS INC | 4,468,114 | $3.525M | 0.6% | $1.81 | — | COM | 471871103 |
| — | VERU INC | 3,800,000 | $2.736M | 0.4% | $0.72 | — | COM | 92536C103 |
| ANAB | ANAPTYSBIO INC | 120,000 | $2.57M | 0.4% | $17.25 | 0.0% | COM | 032724106 |
| — | INOZYME PHARMA INC | 400,000 | $1.704M | 0.3% | $4.25 | — | COM | 45790W108 |
| NUVB | NUVATION BIO INC | 1,000,000 | $1.51M | 0.2% | $1.29 | 0.0% | COM CL A | 67080N101 |
| XLO | XILIO THERAPEUTICS INC | 1,785,000 | $982K | 0.2% | $2.77 | -49.1% | COM | 98422T100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 25,000 | $738K | 0.1% | $30.26 | 0.0% | COM | 604749101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 50,000 | $457K | 0.1% | $8.62 | 0.0% | COM | 71722W107 |
| ACRS | ACLARIS THERAPEUTICS INC | 100,000 | $105K | 0.0% | $3.05 | 0.0% | COM | 00461U105 |